COSM (Cosmos Health) Growth Rank: 1 (As of Jul. 16, 2026) — 50% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

COSM Cosmos Health Inc COSM
29 GF Score
Price $0.28
GF Value $0.36
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Cosmos Health Growth Rank?

Cosmos Health COSM -9.31% 29 Growth Rank is 1 as of Jul. 16, 2026, which is 50% below its 10-year median of 2.00. GuruFocus rates COSM with a GF Score™ of 29/100 and a GF Value™ of $0.36 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Cosmos Health has the Growth Rank of 1.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

COSM vs HKPD, SNYR, YI: Growth Rank Comparison

For the Medical Distribution subindustry, Cosmos Health's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cosmos Health Growth Rank vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cosmos Health's Growth Rank distribution charts can be found below:

* The bar in red indicates where Cosmos Health's Growth Rank falls into.


COSM
29GF Score
Cosmos Health Inc COSM
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 1 mean?
Cosmos Health (COSM) has a Growth Rank of 1 as of Jul. 16, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Cosmos Health and its competitors. This is 50% below median its historical median of 2.00. Over the past decade, Cosmos Health's Growth Rank has ranged from 1.00 to 5.00.
Is Cosmos Health's Growth Rank too high?
Cosmos Health's current Growth Rank of 1 is 50% below median its 10-year median of 2.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 5.00. Overall, Cosmos Health has a GF Score™ of 29/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cosmos Health's Growth Rank compare to HKPD and SNYR?
Cosmos Health's Growth Rank of 1 can be compared against companies in the Medical Distribution industry. Historically, Cosmos Health's own Growth Rank has ranged from 1.00 to 5.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Medical Distribution company?
A good Growth Rank depends on the Medical Distribution industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Cosmos Health and its competitors. Cosmos Health's current Growth Rank is 1, which is 50% below median its own 10-year median of 2.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmos Health stock overvalued right now?
Based on GuruFocus' analysis, Cosmos Health (COSM) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.36, compared to a current price of $0.28 — trading 22.6% below its estimated fair value. The current Growth Rank is 1, which is 50% below median its 10-year median of 2.00. Cosmos Health's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Cosmos Health (COSM), the current Growth Rank is 1 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cosmos Health (COSM) Overvalued in 2026?

Based on GuruFocus' analysis, Cosmos Health stock appears to be undervalued. The current stock price of $0.28 is trading 22.6% below its estimated GF Value™ of $0.36. GuruFocus considers Cosmos Health to be Modestly Undervalued.

Key valuation signals for COSM:

  • Growth Rank: 1 (50% below median its 10-year median of 2.00)
  • GF Value™: $0.36 vs. price of $0.28 (22.6% below fair value)
  • GF Score™: 29/100 with 6 warning signs

No single metric tells the full story. See the COSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cosmos Health Business Description

Other Exchanges V67A:Germany
Address 5 Agiou Georgiou Street, Pilea, Thessaloniki, GRC, 55438
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
29GF Score

Get the complete analysis for COSM

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.28
Price
$0.36
GF Value